However, in specific molecular contexts, miR-370 adopts an oncogenic role, promoting tumor progression by targeting tumor suppressors such as PTEN and TP53 and by modulating cytokine expression and inflammatory signaling within the tumor microenvironment [74,75,76,77,78,79]. The gene discussed is TP53; the disease is neoplasm.